Advent Life Sciences

Advent Life Sciences stands as a premier venture investor, dedicated to fostering innovation and growth within the Life Sciences sector across the UK, Europe, and the USA. With a wealth of experience, Advent Life Sciences excels at transforming groundbreaking scientific discoveries into approved medicines and medical products, driving advancements in healthcare and delivering significant value to patients and investors alike.

Focusing on early and mid-stage companies, Advent Life Sciences employs a first-in-class or best-in-class approach to investment, targeting new drug discovery—including small molecules, biologics, and new modalities—as well as med tech, enabling technologies, and vaccines. Operating from its primary location in London | Investing Transatlantically, GB, the firm leverages its intellectual capital and extensive network to support its investments and work closely with management teams to realize their visions.

Advent Life Sciences is committed to achieving superior financial returns by bringing cutting-edge innovation to patients worldwide. The firm’s dedication to the Life Sciences is evident in its portfolio of companies, which, since 2000, have successfully developed and launched fourteen approved medicines and products. Advent Life Sciences continues to drive progress in the industry, benefiting patients, physicians, and investors. We invite the manager of Advent Life Sciences to create a customized and exclusive company showcase and product listing on our platform.